Company Overview and News

 
Suez: Opaque Income Statements, Misleading FCF Yields And Secular Decline

2018-01-24 seekingalpha
At a first glance, Suez looks cheap on Revenue, FCF, Dividend Yield, EBITDA, EBIT, and Earnings multiples.
Upvote Downvote

 
Mergers And Acquisitions - Capturing The Gain (Of Acquirees)

2017-05-23 seekingalpha
A few weeks ago, SA published an article of mine entitled, "Mergers And Acquisitions: Beating the Odds (With Acquirers)". In it, I explained that while M&A's have a lot of sex appeal, for acquirers and their shareholders, most fail to deliver. This implies that acquirer-investors should focus on high probability combinations and defer decisions on the rest.
Upvote Downvote

 
Global Zero Liquid Discharge (ZLD) Market to Reach US$ 1,002.4 Mn by 2025 - Persistence Market Research

2017-05-11 prnewswire
Several water treatment facilities across the globe have started using zero liquid discharge (ZLD) technology for purifying wastewater. This new-age technology is capable of recycling and decontaminating wastewater without letting a single drop of water go to waste at the end of the treatment cycle. Enforcement of stringent laws on waste water management is expected to further drive the adoption of ZLD technology in the near future.
Upvote Downvote

 
Analysis - Peugeot-Opel deal promises Big Bang in small cars - sources

2017-02-23 in.reuters
PARIS French carmaker PSA Group (PEUP.PA) is planning an engineering blitz to redevelop Opel's core models with its own technology if it succeeds in buying General Motors' (GM.N) European arm, company sources and advisers told Reuters.
Upvote Downvote

 
UPDATE 1-Suez Environnement might bid for GE's water treatment business

2017-02-23 reuters
PARIS Feb 23 French waste and water treatment group Suez Environnement is considering making a bid for General Electric's industrial water treatment business, a Suez spokeswoman said on Thursday, confirming media reports.
Upvote Downvote

 
PRESS DIGEST- Canada- Feb 23

2017-02-23 reuters
Feb 23 The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Upvote Downvote

 
GEM Notice

2017-02-03 londonstockexchange
The board of the Irish Stock Exchange approves the admission of the undermentioned securities to listing on the Official List and trading on the Global Exchange Market of the ISE.
Upvote Downvote

 
A French Pipe Dream - Bloomberg Gadfly

2016-12-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Veolia Environnement's (VE) CEO Antoine Frerot on Q1 2015 Results - Earnings Call Transcript

2016-10-31 seekingalpha
Ladies and gentlemen, welcome to the Veolia conference call for the First Half Results 2015. I now hand over to Mr. Frerot and Mr. Capron. Gentlemen, please go ahead.
Upvote Downvote

 
Suez Environnement (SZEVF) Q3 2016 Results - Earnings Call Transcript

2016-10-29 seekingalpha
Thank you. Good morning, ladies and gentlemen. Thank you all for attending the conference call regarding Suez's nine month results publication. As usual, we have released this morning our revenue, EBITDA, EBIT and net financial debt figures for the nine month period ending September 30th. As you will notice that set of figures puts us at the end of September on the trajectory of our annual objectives, our yearly objective as disclosed in February this year.
Upvote Downvote

1
Waste to Energy (WtE) Market Outlook 2016-2026

2016-10-25 prnewswire
Report Details Visiongain assesses that the global waste-to-energy market will experience Capex of $11,772m in 2016. Read on to discover the potential business opportunities available. It is very easy to confuse waste incinerators of the past with modern waste-to-energy plants. However, the truth is that the current performance of the WtE industry is irreproachable. While there is an obvious need to prevent the excessive generation of global waste, the technologies for energy-from-waste recovery can assume a central part in mitigating the problem.
Upvote Downvote

 
Not What The Doctor Ordered: Pulling The Plug On Chinese Zombies

2016-10-07 seekingalpha
A merger and acquisition spurt is unlikely to fundamentally alter industrial output or solve the problem of overcapacity. Privatization, as alternative, could be made a priority.
Upvote Downvote

 
Pargesa and GBL: A Tale of Two Discounts

2016-09-19 seekingalpha
This article is both an update to an earlier article from a few months ago about the European holding companies Pargesa and GBL, and an attempt to more thoroughly untangle the cash positions of both companies. This turned out to be a little more difficult than I originally thought and is perhaps an interesting lesson for readers that may not be too familiar with consolidated accounting.
Upvote Downvote

 
Suez Environnement Company's (SZEVF) on Q3 2015 Results - Earnings Call Transcript

2016-09-18 seekingalpha
Welcome to the Suez Q3 2015 Results Conference Call. Today's conference is being recorded. At this time I would like to turn the conference over to Christophe Cros, CFO of Suez. Please go ahead.
Upvote Downvote

 
Suez Environnement's (SZEVF) CEO Jean-Louis Chaussade on First half 2016 Results - Earnings Call Transcript

2016-07-31 seekingalpha
Suez Environnement Co SA (OTCPK:SZEVF) First half 2016 Results Conference Call July 28, 2016 2:30 AM ET
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...